Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice

BACKGROUND: Gaps in current evidence and guidance leave clinicians with unanswered questions on the use of cladribine tablets for the treatment of multiple sclerosis (MS) in the era of the COVID-19 pandemic, in particular relating to COVID-19 vaccination. OBJECTIVE: We describe a consensus-based pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Rieckmann, Peter, Centonze, Diego, Giovannoni, Gavin, Hua, Le H., Oreja-Guevara, Celia, Selchen, Daniel, Sørensen, Per Soelberg, Vermersch, Patrick, Wiendl, Heinz, Salloukh, Hashem, Yamout, Bassem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655448/
https://www.ncbi.nlm.nih.gov/pubmed/34899987
http://dx.doi.org/10.1177/17562864211058298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655448/
https://www.ncbi.nlm.nih.gov/pubmed/34899987
http://dx.doi.org/10.1177/17562864211058298

Ejemplares similares